Hintermann Series H3 Total Ankle Replacement Failure Warning Issued by FDA
FDA has not yet determined the cause of a high rate of Hintermann Series H3 total ankle replacement failures, which may be impacting 16% of patients.
FDA has not yet determined the cause of a high rate of Hintermann Series H3 total ankle replacement failures, which may be impacting 16% of patients.
While some patients are receiving Exactech recall letters, warning that their knee and ankle implants may fail prematurely, many who already required revision surgery may never learn their implant was recalled.
Plastic polyethylene inserts sold with 147,732 recalled Exactech knee replacements may degrade and wear out, causing failure rates 3 to 7 times higher than other total knee replacement systems